GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (WBO:1SXP) » Definitions » Net Interest Income

Schott Pharma AG KGaA (WBO:1SXP) Net Interest Income : €-8.9 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Schott Pharma AG KGaA's net interest income for the three months ended in Dec. 2024 was €-3.3 Mil. Its net interest income for the trailing twelve months (TTM) ended in Dec. 2024 was €-8.9 Mil.

Schott Pharma AG KGaA Net Interest Income Historical Data

The historical data trend for Schott Pharma AG KGaA's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Net Interest Income Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
Net Interest Income
-3.15 -4.63 -6.85 -2.30 -7.94

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.38 -2.08 -2.03 -1.45 -3.35

Schott Pharma AG KGaA Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-8.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Schott Pharma AG KGaA Net Interest Income Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Schott Pharma AG KGaA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (WBO:1SXP) » Definitions » Net Interest Income
Comparable Companies
XTER:FIE XTER:AFX XTER:GXI ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN COO BAX WST ALGN HOLX NZSE:FPH SOLV
Traded in Other Exchanges
SHTPY:USA 1SXPd:UK 1SXP:Germany
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Website
https://www.schott-pharma.com
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines